Effects of influenza immunization on humoral and cellular alloreactivity in humans
about
Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspectiveDifferential influenza H1N1-specific humoral and cellular response kinetics in kidney transplant patients.Antibody persistence 1 year after pandemic H1N1 2009 influenza vaccination and immunogenicity of subsequent seasonal influenza vaccine among adult organ transplant patients.Impact of squalene-based adjuvanted influenza vaccination on graft outcome in kidney transplant recipients.Effect of the adjuvanted (AS03) A/H1N1 2009 pandemic influenza vaccine on the risk of rejection in solid organ transplant recipients in England: a self-controlled case seriesHumoral response to the influenza A H1N1/09 monovalent AS03-adjuvanted vaccine in immunocompromised patients.Immune response to an adjuvanted influenza A H1N1 vaccine (Pandemrix(®)) in renal transplant recipients.De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients.Efficacy of influenza A H1N1/2009 vaccine in hemodialysis and kidney transplant patientsImpact of adjuvanted H1N1 vaccine on cell-mediated rejection in heart transplant recipients.Influenza A/H1N1 vaccine in patients treated by kidney transplant or dialysis: a cohort studyAntibody response to the non-adjuvanted and adjuvanted influenza A H1N1/09 monovalent vaccines in renal transplant recipients.Poor seroprotection but allosensitization after adjuvanted pandemic influenza H1N1 vaccine in kidney transplant recipients.Pathogenicity of Bovine Neonatal Pancytopenia-associated vaccine-induced alloantibodies correlates with Major Histocompatibility Complex class I expression.2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.Defining the alloreactive T cell repertoire using high-throughput sequencing of mixed lymphocyte reaction cultureEvaluation of alloreactivity in kidney transplant recipients treated with antithymocyte globulin versus IL-2 receptor blocker.Impact of immunosuppression on recall immune responses to influenza vaccination in stable renal transplant recipientsInfluenza vaccination in the organ transplant recipient: review and summary recommendations.TCR cross-reactivity and allorecognition: new insights into the immunogenetics of allorecognition.Changing face of vaccination in immunocompromised hosts.Immunization after kidney transplantation-what is necessary and what is safe?Methodological aspects of anti-human leukocyte antigen antibody analysis in solid organ transplantation.The impact of vaccination on RBC alloimmunization in a murine model.The risks of using allogeneic cell lines for vaccine production: the example of Bovine Neonatal Pancytopenia.Clinical and immunological relevance of antibodies in solid organ transplantation.Disruption of Transplant Tolerance by an "Incognito" Form of CD8 T Cell-Dependent Memory.Characteristics of the specific humoral response in patients with advanced solid tumors after active immunotherapy with a VEGF vaccine, at different antigen doses and using two distinct adjuvants.Randomized, double-blind comparison of standard-dose vs. high-dose trivalent inactivated influenza vaccine in pediatric solid organ transplant patients.Influenza vaccination and humoral alloimmunity in solid organ transplant recipients.
P2860
Q28740919-08933C9F-83CA-4A94-93F2-D2C54403DF02Q30353821-D8D5482D-3CB3-4EDC-AA5B-FBE40FD3911CQ30356208-92F179FB-680E-4809-AA25-3B40EDD858F9Q30372284-265C2BD6-86B7-47E0-8A8F-0ED35D7AA627Q30383985-32D59F4E-3744-4C9F-A37A-28DA251E16E3Q30399281-58DC0953-1E55-4F94-A5EE-5EDACE69039FQ30403135-73823E45-A7FE-4322-9988-C065D77C47B3Q30403833-03C5105C-1E2F-4471-84D8-8AD27C82229AQ30406140-29526C7D-478E-481F-BF88-F88BA6ABDDFEQ30406926-8764EF54-81B4-4CB5-9B2C-70423CD80CD2Q30407134-4F03CBF8-AC59-4D8C-8E22-C468DEB8E463Q30420230-74D17D50-DBF5-4F1E-9C5E-7590C58BD92DQ30421507-1BEDE1E5-06D3-4A7F-A0CE-F449D3B43FE1Q33424887-2920AC2E-DA89-4802-8606-E6903F51A24FQ34390072-F4A9D341-C397-49D8-8F5B-14D8E78F3246Q34446000-7B4D5949-8947-483A-9C16-3265B2D61BB2Q35580676-4FC215E4-A704-461D-9DA5-A35C60D005A0Q36832305-B992B46B-15D4-4F29-9C2D-060329ABACD5Q37940524-500D9E8D-3892-4A46-ADD9-06285648AD35Q37965366-9394B13D-8A86-48A1-880A-6ED0FC4AE3CBQ38225998-9706F73A-0D70-4E46-8F2C-44F13BD66CF8Q38235003-38F794D9-7019-4239-A7FD-0486869B18F8Q38262909-0AB25AAB-8020-4E4B-8413-56166066D589Q38672985-7BA4E2BB-1525-440C-9CD7-D2C20A377F48Q38734701-2591EAB1-303D-4FCC-8BB6-3C6C2AF0D0E3Q39015291-78FF9ACC-374D-4494-9A5B-7232AD7C4817Q40380028-5DF71792-FA75-4B85-ABA1-D7DCB2E64A99Q41147045-07BE16FD-B963-4F75-9969-072EE0457505Q42176587-10CE1B7E-D8B4-4596-96F0-A08681CC1787Q42220410-FCC7AA92-4340-4E68-AA4A-9F695DF3894F
P2860
Effects of influenza immunization on humoral and cellular alloreactivity in humans
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Effects of influenza immunization on humoral and cellular alloreactivity in humans
@ast
Effects of influenza immunization on humoral and cellular alloreactivity in humans
@en
type
label
Effects of influenza immunization on humoral and cellular alloreactivity in humans
@ast
Effects of influenza immunization on humoral and cellular alloreactivity in humans
@en
prefLabel
Effects of influenza immunization on humoral and cellular alloreactivity in humans
@ast
Effects of influenza immunization on humoral and cellular alloreactivity in humans
@en
P2093
P2860
P1433
P1476
Effects of influenza immunization on humoral and cellular alloreactivity in humans
@en
P2093
Deirdre Sawinski
Donald E Hricik
Emilio D Poggio
Hanni Siegel
Joshua J Augustine
Kristen Kramer
Lara Danziger-Isakov
Leonid Cherkassky
Marie Budev
Mary McManamon
P2860
P304
P356
10.1097/TP.0B013E3181CA56F8
P577
2010-04-01T00:00:00Z